c-Fos is required for TGFβ1 production and the associated paracrine migratory effects of human colon carcinoma cells
c-Fos is required for TGFβ1 production and the associated paracrine migratory effects of human colon carcinoma cells
复制标题
DOI:
10.1002/mc.20189
复制
发表时间:
2006-08-01
影响因子:
4.6
通讯作者:
Mulder, Kathleen M.
中科院分区:
文献类型:
--
作者:
Liu, Guangming;Ding, Wei;Mulder, Kathleen M.
In tumor cells that have lost responsiveness to the growth inhibitory effects of transforming growth factor P (TGFP), increased TGFP production by the tumor cells often contributes to cancer progression, primarily through paracrine mechanisms. Here we investigated the major components of the activator protein-1 (AP-1) complex in the TGF beta 1 promoter of human colon carcinoma cells (HCCCs). In contrast to untransformed epithelial cells (UECs), HCCCs displayed constitutive activation of AP-1 at the proximal AP-1 site in the human TGF beta 1 promoter. Further, in contrast to the JunD and Fra-2 components present in the AP-1 complex at this AP-1 site in UECs, c-Fos was the major detectable AP-1 component in HCCCs. Thus, transcriptional factor switching had occurred in HCCCs relative to the UECs, with regard to the proximal AP-1 site of the human TGF beta 1 promoter. Small interfering RNAs (siRNAs) against cFos significantly suppressed AP-1 activity at the relevant AP-1 site, and led to a decrease in TGFP1 secretion by the HCCCs. Our results indicate for the first time that c-Fos binding at the TGFP1 promoter proximal AP-1 site in HCCCs is required for TGFP1 production by the tumor cells. Further, we demonstrated that blockade of TGFP1 secretion by cFos siRNA led to a suppression of the cellular migration and mitogenesis of NIH 3T3 fibroblasts in a paracrine fashion. Thus, c-Fos may have utility as a target for blocking tumor cell-secreted TGF beta 1, thereby suppressing the migratory behavior associated with the malignant phenotype of HCCCS. (c) 2006 Wiley-Liss, Inc.